BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25528640)

  • 1. Flexible stoichiometry and asymmetry of the PIDDosome core complex by heteronuclear NMR spectroscopy and mass spectrometry.
    Nematollahi LA; Garza-Garcia A; Bechara C; Esposito D; Morgner N; Robinson CV; Driscoll PC
    J Mol Biol; 2015 Feb; 427(4):737-752. PubMed ID: 25528640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex.
    Park HH; Logette E; Raunser S; Cuenin S; Walz T; Tschopp J; Wu H
    Cell; 2007 Feb; 128(3):533-46. PubMed ID: 17289572
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro reconstitution of the interactions in the PIDDosome.
    Jang TH; Zheng C; Wu H; Jeon JH; Park HH
    Apoptosis; 2010 Dec; 15(12):1444-52. PubMed ID: 20872280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PIDD mediates and stabilizes the interaction between RAIDD and caspase-2 for the PIDDosome assembly.
    Jang TH; Park HH
    BMB Rep; 2013 Sep; 46(9):471-6. PubMed ID: 24064063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystallization and preliminary X-ray crystallographic studies of the oligomeric death-domain complex between PIDD and RAIDD.
    Park HH; Wu H
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2007 Mar; 63(Pt 3):229-32. PubMed ID: 17329820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification, crystallization and preliminary x-ray crystallographic studies of RAIDD Death-Domain (DD).
    Jang TH; Park HH
    Int J Mol Sci; 2009 Jun; 10(6):2501-2509. PubMed ID: 19582216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal structure of RAIDD death domain implicates potential mechanism of PIDDosome assembly.
    Park HH; Wu H
    J Mol Biol; 2006 Mar; 357(2):358-64. PubMed ID: 16434054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAIDD mutations underlie the pathogenesis of thin lissencephaly (TLIS).
    Ha HJ; Park HH
    PLoS One; 2018; 13(10):e0205042. PubMed ID: 30281648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of mutation effects on PIDDosome core complex.
    Jang TH; Seo EK; Park HH
    Appl Biochem Biotechnol; 2013 May; 170(1):210-8. PubMed ID: 23494218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caspase-2 activation in the absence of PIDDosome formation.
    Manzl C; Krumschnabel G; Bock F; Sohm B; Labi V; Baumgartner F; Logette E; Tschopp J; Villunger A
    J Cell Biol; 2009 Apr; 185(2):291-303. PubMed ID: 19364921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and analysis of dominant negative mutants of RAIDD and PIDD.
    Jang TH; Bae JY; Park OK; Kim JH; Cho KH; Jeon JH; Park HH
    Biochim Biophys Acta; 2010 Jul; 1804(7):1557-63. PubMed ID: 20406701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of neurodevelopmental disorders caused by pathogenic variants of PIDD.
    Ha HJ; Park HH
    Biochem Biophys Res Commun; 2023 Feb; 645():147-153. PubMed ID: 36689811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIDD death-domain phosphorylation by ATM controls prodeath versus prosurvival PIDDosome signaling.
    Ando K; Kernan JL; Liu PH; Sanda T; Logette E; Tschopp J; Look AT; Wang J; Bouchier-Hayes L; Sidi S
    Mol Cell; 2012 Sep; 47(5):681-93. PubMed ID: 22854598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPM1 directs PIDDosome-dependent caspase-2 activation in the nucleolus.
    Ando K; Parsons MJ; Shah RB; Charendoff CI; Paris SL; Liu PH; Fassio SR; Rohrman BA; Thompson R; Oberst A; Sidi S; Bouchier-Hayes L
    J Cell Biol; 2017 Jun; 216(6):1795-1810. PubMed ID: 28432080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sum is more than the parts: crystal and solution data reveal that the PIDDosome core complex is a dynamic assembly.
    Sprangers R
    J Mol Biol; 2015 Feb; 427(4):715-717. PubMed ID: 25576033
    [No Abstract]   [Full Text] [Related]  

  • 16. Solution NMR investigation of the CD95/FADD homotypic death domain complex suggests lack of engagement of the CD95 C terminus.
    Esposito D; Sankar A; Morgner N; Robinson CV; Rittinger K; Driscoll PC
    Structure; 2010 Oct; 18(10):1378-90. PubMed ID: 20947025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PIDDosome-independent tumor suppression by Caspase-2.
    Manzl C; Peintner L; Krumschnabel G; Bock F; Labi V; Drach M; Newbold A; Johnstone R; Villunger A
    Cell Death Differ; 2012 Oct; 19(10):1722-32. PubMed ID: 22595758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Inhibitor of PIDDosome Formation.
    Thompson R; Shah RB; Liu PH; Gupta YK; Ando K; Aggarwal AK; Sidi S
    Mol Cell; 2015 Jun; 58(5):767-79. PubMed ID: 25936804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuronal caspase 2 activity and function requires RAIDD, but not PIDD.
    Ribe EM; Jean YY; Goldstein RL; Manzl C; Stefanis L; Villunger A; Troy CM
    Biochem J; 2012 Jun; 444(3):591-9. PubMed ID: 22515271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Total recall: the role of PIDDosome components in neurodegeneration.
    Volik PI; Kopeina GS; Zhivotovsky B; Zamaraev AV
    Trends Mol Med; 2023 Dec; 29(12):996-1013. PubMed ID: 37716905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.